219 related articles for article (PubMed ID: 24317448)
1. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP.
Morotti A; Panuzzo C; Crivellaro S; Pergolizzi B; Familiari U; Berger AH; Saglio G; Pandolfi PP
Leukemia; 2014 Jun; 28(6):1326-33. PubMed ID: 24317448
[TBL] [Abstract][Full Text] [Related]
2. HAUSP compartmentalization in chronic myeloid leukemia.
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G
Eur J Haematol; 2015 Apr; 94(4):318-21. PubMed ID: 25082234
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
[TBL] [Abstract][Full Text] [Related]
4. Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.
Morotti A; Torti D; Carra G; Panuzzo C; Crivellaro S; Taulli R; Fava C; Guerrasio A; Saglio G
Curr Drug Targets; 2017; 18(4):389-395. PubMed ID: 27291926
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G; Morotti A
PLoS One; 2014; 9(10):e110682. PubMed ID: 25343485
[TBL] [Abstract][Full Text] [Related]
6. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.
Peng C; Chen Y; Yang Z; Zhang H; Osterby L; Rosmarin AG; Li S
Blood; 2010 Jan; 115(3):626-35. PubMed ID: 19965668
[TBL] [Abstract][Full Text] [Related]
7. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
8. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
Chu S; McDonald T; Bhatia R
Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation.
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Fava C; Guerrasio A; Pandolfi PP; Saglio G
Cell Cycle; 2015; 14(7):973-9. PubMed ID: 25608112
[TBL] [Abstract][Full Text] [Related]
10. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
Iervolino A; Santilli G; Trotta R; Guerzoni C; Cesi V; Bergamaschi A; Gambacorti-Passerini C; Calabretta B; Perrotti D
Mol Cell Biol; 2002 Apr; 22(7):2255-66. PubMed ID: 11884611
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus.
Huang ZL; Gao M; Li QY; Tao K; Xiao Q; Cao WX; Feng WL
Oncotarget; 2013 Dec; 4(12):2249-60. PubMed ID: 24158537
[TBL] [Abstract][Full Text] [Related]
12. Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.
Chatain N; Ziegler P; Fahrenkamp D; Jost E; Moriggl R; Schmitz-Van de Leur H; Müller-Newen G
Oncogene; 2013 Aug; 32(31):3587-97. PubMed ID: 22926520
[TBL] [Abstract][Full Text] [Related]
13. AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells.
Zhou LL; Zhao Y; Ringrose A; DeGeer D; Kennah E; Lin AE; Sheng G; Li XJ; Turhan A; Jiang X
J Exp Med; 2008 Oct; 205(11):2657-71. PubMed ID: 18936234
[TBL] [Abstract][Full Text] [Related]
14. Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.
Reddiconto G; Toto C; Palamà I; De Leo S; de Luca E; De Matteis S; Dini L; Passerini CG; Di Renzo N; Maffia M; Coluccia AM
Blood; 2012 Mar; 119(10):2335-45. PubMed ID: 22262776
[TBL] [Abstract][Full Text] [Related]
15. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.
Frietsch JJ; Kastner C; Grunewald TG; Schweigel H; Nollau P; Ziermann J; Clement JH; La Rosée P; Hochhaus A; Butt E
Oncotarget; 2014 Jul; 5(14):5257-71. PubMed ID: 24913448
[TBL] [Abstract][Full Text] [Related]
16. Intracellular protein trafficking kinetics in chronic myeloid leukemia stem cells using a microfluidic platform.
Faley S; Copland M; Reboud J; Cooper JM
Integr Biol (Camb); 2012 Apr; 4(4):368-73. PubMed ID: 22344285
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells.
Li Q; Huang Z; Gao M; Cao W; Xiao Q; Luo H; Feng W
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257089
[TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia.
Noguera NI; Song MS; Divona M; Catalano G; Calvo KL; García F; Ottone T; Florenzano F; Faraoni I; Battistini L; Colombo E; Amadori S; Pandolfi PP; Lo-Coco F
Leukemia; 2013 Apr; 27(5):1037-43. PubMed ID: 23183427
[TBL] [Abstract][Full Text] [Related]
19. Subcellular distribution of p210(BCR-ABL) in CML cell lines and primary CD34+ CML cells.
Patel H; Marley SB; Greener L; Gordon MY
Leukemia; 2008 Mar; 22(3):559-71. PubMed ID: 18059481
[TBL] [Abstract][Full Text] [Related]
20. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]